CLL-246 Venetoclax-Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukemia: 5-Year Results of the Randomized CLL14 Study

Autor:	Othman Al-Sawaf, Can Zhang, Sandra Robrecht, Alex Kotak, Naomi Chang, Anna Fink, Eugen Tausch, Christof Schneider, Matthias Ritgen, Karl Kreuzer, Brenda Chyla, Barbara Eichhorst, Yanwen Jiang, Stephan Stilgenbauer, Michael Hallek, Kirsten Fischer
Rok vydání:	2022
Předmět:	Cancer Research Oncology Hematology
Zdroj:	Clinical Lymphoma Myeloma and Leukemia. 22:S274-S275
ISSN:	2152-2650
DOI:	10.1016/s2152-2650(22)01339-8
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::7a3b64542ecd1b110127cef2682f5304 https://doi.org/10.1016/s2152-2650(22)01339-8 Zobrazit plný text záznamu Full Text from ScienceDirect